Decoding a brain cancer genome – genetics as well as epigenetics
Stephen Baylin, MD, during a Johns Hopkins Kimmel Cancer Center discusses a how alterations in a DNA formula have been deciphered in a total bid with The Cancer Genome Atlas during a National Cancer Institute to resolve a brain cancer genome